TY - JOUR
T1 - Characterization of a novel tonic γ-aminobutyric acidA receptor-mediated inhibition in magnocellular neurosecretory neurons and its modulation by glia
AU - Jin, Bong Park
AU - Skalska, Silvia
AU - Stern, Javier E.
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2006
Y1 - 2006
N2 - In addition to mediating conventional quantal synaptic transmission (also known as phasic inhibition), γ-aminobutyric acidA (GABA A) receptors have been recently shown to underlie a slower, persistent form of inhibition (tonic inhibition). Using patch-clamp electrophysiology and immunohistochemistry, we addressed here whether a GABAA receptor-mediated tonic inhibition is present in supraoptic nucleus (SON) neurosecretory neurons; identified key modulatory mechanisms, including the role of glia; and determined its functional role in controlling SON neuronal excitability. Besides blocking GABAA-mediated inhibitory postsynaptic currents, the GABAA receptor blockers bicuculline and picrotoxin caused an outward shift in the holding current (Itonic), both in oxytocin and vasopressin neurons. Conversely, the high-affinity antagonist gabazine selectively blocked inhibitory postsynaptic currents. Under basal conditions, Itonic was independent on the degree of synaptic activity but was strongly modulated by the activity GABA transporters (GATs), mostly the GAT3 isoform, found here to be localized in SON glial cells/processes. Extracellular activation of GABAergic afferents evoked a small gabazine-insensitive, bicuculline-sensitive current, which was enhanced by GAT blockade. These results suggest that Itonic may be activated by spillover of GABA during conditions of strong and/or synchronous synaptic activity. Blockade of Itonic increased input resistance, induced membrane depolarization and firing activity, and enhanced the input-output function of SON neurons. In summary, our results indicate that GABAA receptors, possibly of different molecular configuration and subcellular distribution, mediate synaptic and tonic inhibition in SON neurons. The latter inhibitory modality plays a major role in modulating SON neuronal excitability, and its efficacy is modulated by the activity of glial GATs.
AB - In addition to mediating conventional quantal synaptic transmission (also known as phasic inhibition), γ-aminobutyric acidA (GABA A) receptors have been recently shown to underlie a slower, persistent form of inhibition (tonic inhibition). Using patch-clamp electrophysiology and immunohistochemistry, we addressed here whether a GABAA receptor-mediated tonic inhibition is present in supraoptic nucleus (SON) neurosecretory neurons; identified key modulatory mechanisms, including the role of glia; and determined its functional role in controlling SON neuronal excitability. Besides blocking GABAA-mediated inhibitory postsynaptic currents, the GABAA receptor blockers bicuculline and picrotoxin caused an outward shift in the holding current (Itonic), both in oxytocin and vasopressin neurons. Conversely, the high-affinity antagonist gabazine selectively blocked inhibitory postsynaptic currents. Under basal conditions, Itonic was independent on the degree of synaptic activity but was strongly modulated by the activity GABA transporters (GATs), mostly the GAT3 isoform, found here to be localized in SON glial cells/processes. Extracellular activation of GABAergic afferents evoked a small gabazine-insensitive, bicuculline-sensitive current, which was enhanced by GAT blockade. These results suggest that Itonic may be activated by spillover of GABA during conditions of strong and/or synchronous synaptic activity. Blockade of Itonic increased input resistance, induced membrane depolarization and firing activity, and enhanced the input-output function of SON neurons. In summary, our results indicate that GABAA receptors, possibly of different molecular configuration and subcellular distribution, mediate synaptic and tonic inhibition in SON neurons. The latter inhibitory modality plays a major role in modulating SON neuronal excitability, and its efficacy is modulated by the activity of glial GATs.
UR - http://www.scopus.com/inward/record.url?scp=33746083203&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746083203&partnerID=8YFLogxK
U2 - 10.1210/en.2006-0218
DO - 10.1210/en.2006-0218
M3 - Article
C2 - 16675519
AN - SCOPUS:33746083203
SN - 0013-7227
VL - 147
SP - 3746
EP - 3760
JO - Endocrinology
JF - Endocrinology
IS - 8
ER -